#United States #New York #EHE Health #VO2 Max #Seismofit

EHE Health Introduces Innovative VO2 Max Testing

EHE Health, a leading provider of preventive healthcare in the United States, has made a significant stride in health assessment by introducing a pioneering VO2 max testing innovation, aimed at improving how patients understand and manage their health. This advanced testing, known as Seismofit, was developed by the Danish technology firm VentriJect and has made its way to the U.S., providing a solution that promises to make VO2 max readings more accessible than ever.

Traditionally, measuring VO2 max—the maximum amount of oxygen utilized during intense exercise—required physical exertion through tests like a cardiopulmonary exercise test (CPET) or a 3-minute step test. However, the Seismofit sensor changes the game by providing a resting VO2 max reading within minutes, negating the requirement for any strenuous activity. This innovation is particularly beneficial for older adults and individuals with physical limitations, as it empowers them to gain vital health insights without the stress of conventional exercise tests.

How Seismofit Works

The Seismofit technology relies on a method called seismocardiography, where a small sensor detects minute movements in the chest caused by heartbeats. This data is then processed using a sophisticated proprietary algorithm, which delivers a clinically validated estimate of VO2 max. Such readings are crucial indicators of cardiorespiratory fitness (CRF), correlating strongly with overall health.

The significance of VO2 max extending beyond athletic performance has led health authorities like the American Heart Association to advocate for its routine examination as it reflects one's health status. EHE Health's Chief Medical Officer, Dr. Jacqueline King, discusses the importance of this cutting-edge advancement, stating, "Resting VO2 max offers a more accurate and inclusive method for evaluating cardiorespiratory fitness across diverse activity levels."

EHE Health's Commitment to Preventive Care

This innovation is part of EHE Health's broader commitment to enhancing preventive healthcare practices. CEO Greg Mansur expressed that introducing Seismofit aligns with the company's vision of refining clinical protocols to enable patients to better manage their long-term health. As the first national provider network to utilize this groundbreaking technology, EHE Health sets new standards in preventive care delivery.

COO of VentriJect, Mikkel Kristiansen, highlighted the importance of this collaboration, noting that while VO2 max is a standard measurement for elite athletes, its application in healthcare has been limited. "This deployment with EHE Health is monumental for both our expansion in North America and for patients who seek to better understand their health through VO2 max readings," Kristiansen emphasized.

Conclusion and Future Implementation

As part of EHE Health's ongoing evolution, the VO2 max test is being rolled out across its managed clinics in the U.S., with full implementation anticipated by mid-2026. This move is set to transform the landscape of preventive healthcare, putting critical health information directly into the hands of patients and empowering them to take proactive measures towards their health.

EHE Health, headquartered in New York City and operating over 200 clinics nationwide, has a long-standing history of innovative health solutions. After more than a century of service in preventive care, the introduction of Seismofit marks yet another chapter in their mission to help individuals lead healthier, longer lives through personalized healthcare solutions. To learn more about their offerings, visit EHE Health's website.